Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low–Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Resource Type
Article
Authors
Cartron, Guillaume ; Bachy, Emmanuel ; Tilly, Hervé ; Daguindau, Nicolas ; Pica, Gian-Matteo ; Bijou, Fontanet ; Mounier, Christiane ; Clavert, Aline ; Damaj, Gandhi Laurent ; Slama, Borhane ; Casasnovas, Olivier ; Houot, Roch ; Bouabdallah, Krimo ; Sibon, David ; Fitoussi, Olivier ; Morineau, Nadine ; Herbaux, Charles ; Gastinne, Thomas ; Fornecker, Luc-Matthieu ; Haioun, Corinne
Source
Journal of Clinical Oncology; 7/1/2023, Vol. 41 Issue 19, p3523-3533, 11p
Subject
Language
ISSN
0732183X